Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kan Xue

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
BMC Gastroenterology|May 23, 2026
Comparison of surgical safety among different comprehensive treatment models for adenocarcinoma of esophagogastric junction: a single-center cohort studyHongmei Dai, Yinkui Wang, Fei Shan, et al.
Plos One|January 26, 2018
Correlation of pathological complete response with survival after neoadjuvant chemotherapy in gastric or gastroesophageal junction cancer treated with radical surgery: A meta-analysisZiyu Li, Fei Shan, Yinkui Wang, et al.
Zhonghua Wei Chang Wai Ke Za Zhi = Chinese Journal of Gastrointestinal Surgery|March 2, 2018
[Current status of diagnosis and treatment of early gastric cancer in China--Data from China Gastrointestinal Cancer Surgery Union]Yinkui Wang, Ziyu Li, Fei Shan, et al.
World Journal of Surgical Oncology|July 11, 2023
Efficacy of chemotherapy versus surgery as initial treatment for gastric cancer with positive peritoneal cytologyBailong Li, Rulin Miao, Fei Shan, et al.
BMC Gastroenterology|July 11, 2021
Combination of tumor markers predicts progression and pathological response in patients with locally advanced gastric cancer after neoadjuvant chemotherapy treatmentZining Liu, Yinkui Wang, Fei Shan, et al.
Annals of Surgical Oncology|November 22, 2023
Pre- and Post-treatment Double-Sequential-Point Dynamic Radiomic Model in the Response Prediction of Gastric Cancer to Neoadjuvant Chemotherapy: 3-Year Survival AnalysisYinkui Wang, Lei Tang, Xiangji Ying, et al.
Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu|October 6, 2022
Laparoscopic <i>vs</i>. open lower mediastinal lymphadenectomy for Siewert type II/III adenocarcinoma of esophagogastric junction: An exploratory, observational, prospective, IDEAL stage 2b cohort study (CLASS-10 study)Shuangxi Li, Xiangji Ying, Fei Shan, et al.
Frontiers in Oncology|December 20, 2021
Duration of Perioperative Chemotherapy in Locally Advanced Gastric Cancer: A "Less Is More" Question When ypN0 Is AchievedZining Liu, Yinkui Wang, Fei Shan, et al.
Annals of Surgical Oncology|July 30, 2021
Treatment Switch in Poor Responders with Locally Advanced Gastric Cancer After Neoadjuvant ChemotherapyZining Liu, Yinkui Wang, Fei Shan, et al.
Surgical Endoscopy|January 25, 2024
Safety and short-term outcomes of a modified valvuloplastic esophagogastrostomy versus gastric tube anastomosis after laparoscopy-assisted proximal gastrectomy: a retrospective cohort studyBailong Li, Yinkui Wang, Zhouqiao Wu, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
BMC Gastroenterology|May 23, 2026
Comparison of surgical safety among different comprehensive treatment models for adenocarcinoma of esophagogastric junction: a single-center cohort studyHongmei Dai, Yinkui Wang, Fei Shan, et al.
Plos One|January 26, 2018
Correlation of pathological complete response with survival after neoadjuvant chemotherapy in gastric or gastroesophageal junction cancer treated with radical surgery: A meta-analysisZiyu Li, Fei Shan, Yinkui Wang, et al.
Zhonghua Wei Chang Wai Ke Za Zhi = Chinese Journal of Gastrointestinal Surgery|March 2, 2018
[Current status of diagnosis and treatment of early gastric cancer in China--Data from China Gastrointestinal Cancer Surgery Union]Yinkui Wang, Ziyu Li, Fei Shan, et al.
World Journal of Surgical Oncology|July 11, 2023
Efficacy of chemotherapy versus surgery as initial treatment for gastric cancer with positive peritoneal cytologyBailong Li, Rulin Miao, Fei Shan, et al.
BMC Gastroenterology|July 11, 2021
Combination of tumor markers predicts progression and pathological response in patients with locally advanced gastric cancer after neoadjuvant chemotherapy treatmentZining Liu, Yinkui Wang, Fei Shan, et al.
Annals of Surgical Oncology|November 22, 2023
Pre- and Post-treatment Double-Sequential-Point Dynamic Radiomic Model in the Response Prediction of Gastric Cancer to Neoadjuvant Chemotherapy: 3-Year Survival AnalysisYinkui Wang, Lei Tang, Xiangji Ying, et al.
Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu|October 6, 2022
Laparoscopic <i>vs</i>. open lower mediastinal lymphadenectomy for Siewert type II/III adenocarcinoma of esophagogastric junction: An exploratory, observational, prospective, IDEAL stage 2b cohort study (CLASS-10 study)Shuangxi Li, Xiangji Ying, Fei Shan, et al.
Frontiers in Oncology|December 20, 2021
Duration of Perioperative Chemotherapy in Locally Advanced Gastric Cancer: A "Less Is More" Question When ypN0 Is AchievedZining Liu, Yinkui Wang, Fei Shan, et al.
Annals of Surgical Oncology|July 30, 2021
Treatment Switch in Poor Responders with Locally Advanced Gastric Cancer After Neoadjuvant ChemotherapyZining Liu, Yinkui Wang, Fei Shan, et al.
Surgical Endoscopy|January 25, 2024
Safety and short-term outcomes of a modified valvuloplastic esophagogastrostomy versus gastric tube anastomosis after laparoscopy-assisted proximal gastrectomy: a retrospective cohort studyBailong Li, Yinkui Wang, Zhouqiao Wu, et al.
Pageof 3